Predictors of in-hospital and 30-day complications of peripheral vascular interventions using bivalirudin as the primary anticoagulant: Results from the APPROVE registry

Journal of Invasive Cardiology

Volumn 17, Issue 7, 2005, Pages 356-359

  Shammas, Nicolas W ^a   Allie, David ^a   Hall, Patrick ^a   Young, John ^a   Laird, John ^a   Safian, Robert ^a   Virmani, Ajay ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN RECEPTOR ANTAGONIST; HIRULOG; ANTICOAGULANT AGENT; HIRUDIN DERIVATIVE; PEPTIDE FRAGMENT; RECOMBINANT PROTEIN;

ADULT; ANTICOAGULATION; ARTICLE; BLEEDING TENDENCY; BOLUS INJECTION; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG INFUSION; HEART DEATH; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; LEG AMPUTATION; LENGTH OF STAY; LOGISTIC REGRESSION ANALYSIS; MEDICAL ASSESSMENT; MULTICENTER STUDY; PERIPHERAL VASCULAR DISEASE; PREDICTION; SEX RATIO; AGED; BLEEDING; CATHETERIZATION; FEASIBILITY STUDY; FEMALE; FEMORAL ARTERY; ILIAC ARTERY; ISCHEMIA; MALE; PROSPECTIVE STUDY; REGISTER; RENAL ARTERY; RISK FACTOR; TIME; TREATMENT OUTCOME;

AGED; ANTICOAGULANTS; CATHETERIZATION, PERIPHERAL; FEASIBILITY STUDIES; FEMALE; FEMORAL ARTERY; HEMORRHAGE; HIRUDINS; HOSPITALIZATION; HUMANS; ILIAC ARTERY; ISCHEMIA; MALE; PEPTIDE FRAGMENTS; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS; REGISTRIES; RENAL ARTERY; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 26944442454     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Allie DE, Hall P, Shammas NW, et al. The Angiomax Peripheral Procedure Registry of Vascular Events Trial (APPROVE): Inhospital and 30-day results. J Invasive Cardiol 2004;16:651-656.
2. Becker GJ, McClenny TE, Kovacs ME, et al. The importance of increasing public and physician awareness of peripheral arterial disease. J Vasc Interv Radiol 2002;13:7-11.
3. McDaniel MD, Cronenwett JL. Basic data related to the natural history of intermittent claudication. Ann Vasc Surg 1989;3:273-277.
4. Matsi PJ, Manninen HI. Complications of lower-limb percutaneous transluminal angioplasty: A prospective analysis of 410 procedures on 295 consecutive patients. Cardiovasc Intervent Radiol 1998;21:361-366.
5. Gutteridge W, Torrie EP, Galland RB. Cumulative risk of bypass, amputation or death following percutaneous transluminal angioplasty. Eur J Vasc Endovasc Surg 1997;14:134-139.
6. Axisa B, Fishwick G, Bolia A, et al. Complications following peripheral angioplasty. Ann R Coll Surg Engl 2002;84:39-42.
7. Morse MH, Jeans WD, Cole SE, et al. Complications in percutaneous transluminal angioplasty: Relationships with patient age. Br J Radiol 1991;64:5-9.
8. Hasson JE, Acher CW, Wojtowycz M, et al. Lower extremity percutaneous transluminal angioplasty: Multifactorial analysis of morbidity and mortality. Surgery 1990;108:748-752.
9. Boyer L, Therre T, Garcier JM, et al. Infrapopliteal percutaneous transluminal angioplasty for limb salvage. Acta Radiol 2000;41:73-77.
10. Greenfield AJ. Femoral, popliteal, and tibial arteries: percutaneous transluminal angioplasty. AJR Am J Roentgenol 1980;135:927-935.
11. Shammas NW, Lemke JH, Dippel EJ, et al. In-hospital complications of peripheral vascular interventions using unfractionated heparin as the primary anticoagulant. J of Invas Cardiol 2003;15:242-246.
12. Ogilby JD, Kopelman HA, Klein LW, Agarwal JB. Adequate heparinization during PTCA: Assessment using activated clotting times. Cathet Cardiovasc Diagn 1989;18:206-209.
13. Chew DP, Bhatt DL, Kimball W, et al. Bivalirudin provides increasing benefit with decreasing renal function: a meta-analysis of randomized trials. Am J Cardiol 2003;92:919-23.
14. Minutello RM, Chou ET, Hong MK, et al. Impact of body mass index on in-hospital outcomes following percutaneous coronary intervention (report from the New York State Angioplasty Registry). Am J Cardiol 2004;93:1229-1232.
15. Krikorian RK, Kramer PH, Vacek JL. Percutaneous revascularization of lower extremity arterial disease in females compared to males. J Invasive Cardiol 1997;9:333-338.